238 related articles for article (PubMed ID: 15475228)
1. Insulin resistance and obesity.
Greenfield JR; Campbell LV
Clin Dermatol; 2004; 22(4):289-95. PubMed ID: 15475228
[TBL] [Abstract][Full Text] [Related]
2. Metabolic implications of obesity: before and after gastric bypass.
Richardson DW; Vinik AI
Gastroenterol Clin North Am; 2005 Mar; 34(1):9-24. PubMed ID: 15823435
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome.
Garber AJ
Med Clin North Am; 2004 Jul; 88(4):837-46, ix. PubMed ID: 15308381
[TBL] [Abstract][Full Text] [Related]
4. Sleep apnea is a manifestation of the metabolic syndrome.
Vgontzas AN; Bixler EO; Chrousos GP
Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
6. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of insulin resistance and associated diseases.
Mlinar B; Marc J; Janez A; Pfeifer M
Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome: practical guide to origins and treatment: Part I.
Wilson PW; Grundy SM
Circulation; 2003 Sep; 108(12):1422-4. PubMed ID: 14504251
[No Abstract] [Full Text] [Related]
10. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
[TBL] [Abstract][Full Text] [Related]
11. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
Ganne S; Arora S; Karam J; McFarlane SI
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):201-11. PubMed ID: 17338665
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and polycystic ovary syndrome.
Galluzzo A; Amato MC; Giordano C
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
[TBL] [Abstract][Full Text] [Related]
14. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.
Hung J; McQuillan BM; Chapman CM; Thompson PL; Beilby JP
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1268-73. PubMed ID: 15790931
[TBL] [Abstract][Full Text] [Related]
15. [Weight of obesity in (pre)type 2 diabetes in children and adolescents: how and when to screen for?].
Mouraux T; Dorchy H
Arch Pediatr; 2005 Dec; 12(12):1779-84. PubMed ID: 16289780
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
Qatanani M; Lazar MA
Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
Schernthaner GH; Schernthaner G
Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
[TBL] [Abstract][Full Text] [Related]
18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
19. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in obese Turkish children and adolescents.
Atabek ME; Pirgon O; Kurtoglu S
Diabetes Res Clin Pract; 2006 Jun; 72(3):315-21. PubMed ID: 16325296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
